EP3689383

Unitary patent

CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN

Filed

Mar 15, 2013

Technology

Chemistry · Biotechnology +1

UPC cases

EPO proceedings

Ownership history

As recorded at the EPO. Transfers made after the opposition period are recorded in national registers and may be missing here.

Hover an owner to see their dates

The United States Of America, As Represented By The Secretary, Department of Health and Human Servicessince Oct 31, 2025
The U.S.A. as represented by the Secretary, Department of Health and Human ServicesJul 3, 2020 – Oct 31, 2025

Abstract

The invention provides an isolated and purified nucleic acid sequence encoding a chimeric antigen receptor (CAR) directed against B-cell Maturation Antigen (BCMA). The invention also provides host cells, such as T-cells or natural killer (NK) cells, expressing the CAR and methods for destroying multiple myeloma cells.

Litigation history

Date	Case	Division	Type	Outcome	Parties
Sep 23, 2026	UPC CFI 29/2026	Brussels LD	Infringement	Locked	2seventy bio, Inc. +18

Additional proceedings on this patent

Start 14-day free trialOutcomes, the additional proceedings and the register history.Already a user? Sign in